FAST NEWS: Antengene Corporation Announces First Ever Revenue of $7.8 Million
The latest: Antengene Corp. Ltd. (6996.HK), a biopharmaceutical company, announced Thursday it expects revenue for the six months ended June 30 this year to range from 53 million yuan ($7.8…
RECENT ARTICLES
-
Investors cheer Akeso’s revenue milestone, even as it returns to the red
9926.HK -
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
NaaS drives into third quarter with first-ever quarterly non-IFRS profit
NAAS.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Cancer drug maker Biostar shines on Hong Kong market debut
2563.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
